What Indira IVF does

Indira IVF Hospital Limited, headquartered in Udaipur and founded in 1988, operates India's largest chain of specialty fertility clinics with 200+ centres spread across more than 20 states. The company delivers a comprehensive assisted reproductive technology (ART) portfolio spanning IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser-assisted hatching, cryopreservation, and donor programmes (ovum, embryo, sperm), alongside advanced diagnostics such as PGT-A, Micro TESE, and DNA Fragmentation Index testing. Supporting clinical operations are proprietary laboratory platforms including a Closed Working Chamber, Electronic Witness Technology, 24X7 monitoring, a Microfluidic Sperm Sorter, an IoT-based Labcare Monitoring and Alarming System (minute-level telemetry with deviation alerts), and an Air Monitoring System tracking TVOC, CO2, PM2.5, humidity, and temperature.

The company serves individual patients — primarily couples facing tubal-peritoneal, male factor, endometriosis, anovulation, or unexplained infertility, plus women seeking elective egg freezing. Revenue is generated on a pay-as-you-go per-cycle basis, with IVF treatments priced between Rs 1.2 lakh and Rs 2.5 lakh per cycle and zero-interest EMI options offered through third-party financiers. Go-to-market is sales-led via direct clinic presence rather than third-party distribution, supported by content marketing (blog, YouTube, fertility calculators, a personalized success-rate calculator) that drives organic top-of-funnel demand.

Indira IVF is a privately held company backed by Swedish private equity firm EQT (BPEA EQT), which invested $656 million in 2024. The company has received SEBI approval for a planned Rs 3,500 crore IPO via the confidential pre-filing route and is using the proceeds window to consolidate geographic gaps — exemplified by the April 2026 acquisition of Kolkata-based Abha Surgy Healthcare, the June 2026 Whitefield (Bengaluru) upgrade, and the June 2026 Hassan greenfield. Indira Fertility Academy functions as an in-house training and credentialing arm, supplying the clinical talent pipeline. The leadership team is a mix of founder-family directors (Ajay Murdia as Chairman, Kshitiz Murdia, Nitiz Murdia, Manish Khatri) and appointed CXOs covering operations, medical excellence, finance/legal, and international business.

Name

Indira IVF

Legal name

Indira IVF Hospital Limited

Website

https://indiraivf.com

Company type

Private

Founded year

1988

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Indira IVF Hospital Limited is India's largest single-specialty fertility chain, operating 200+ centres across 20+ states and offering IVF, ICSI, IUI, advanced ART, and cryopreservation services to individual patients experiencing infertility. The company is EQT-backed, preparing a Rs 3,500 crore IPO.

Ownership category

akta.pro rank

Product category

Fertility Clinics

NAICS

Family Planning Centers (62141)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)

Keywords

• IVF treatment services
• Fertility clinic services
• Assisted reproductive technology
• Infertility treatment
• Fertility preservation

Headquarters

HQ city

Udaipur

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Fertility Treatment Services: Indira IVF generates revenue through providing comprehensive fertility treatments including IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser assisted hatching, and advanced treatments. Services include infertility testing, fertility preservation (cryopreservation), and donor programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Indira IVF operates a chain of specialty fertility clinics delivering assisted reproductive technology (ART) services including IVF, ICSI, IUI, laparoscopy, hysteroscopy, blastocyst culture and embryo transfer, laser assisted hatching, fertility preservation (cryopreservation), donor programs (egg, embryo, sperm), advanced treatments (PGT-A, Micro TESE, DFI, PLI), and infertility diagnostics. Treatments are delivered through 200+ centers across more than 20 Indian states using standardized clinical protocols and advanced laboratory systems.

Product overview

Indira IVF operates as a chain of specialty fertility clinics offering a comprehensive portfolio of assisted reproductive technology (ART) services. The core offerings include IVF (In Vitro Fertilization), ICSI (Intracytoplasmic Sperm Injection), IUI (Intrauterine Insemination), laparoscopy, and hysteroscopy procedures. Advanced treatments include Micro TESE, PGT-A (Preimplantation Genetic Testing), DNA Fragmentation Index testing, and cryopreservation services for eggs, sperm, and embryos. The company provides donor programs (ovum, embryo, and sperm donation) and diagnostic services including infertility workup, semen analysis, and sonography. Supporting the clinical services are technology platforms including Closed Working Chamber, Electronic Witness Technology, 24X7 Monitoring System, Microfluidic Sperm Sorter, Labcare Monitoring and Alarming System, and Air Monitoring System. Indira IVF also operates Indira Fertility Academy offering professional training courses. The company has expanded to over 200 centres across India, making it India's largest IVF chain.

Differentiator

Problem solved

Functional benefit

Products and services

• In Vitro Fertilization (IVF) A fertility treatment where fertilization and embryo development happen outside the uterus followed by the Embryo Transfer Procedure; offered to couples unable to conceive naturally.
• Intracytoplasmic Sperm Injection (ICSI) A variation of IVF where a single sperm is injected directly into the female egg for fertilization; targeted at male factor infertility cases.
• Intrauterine Insemination (IUI) Procedure where top-quality sperm of a male partner are injected into the female's reproductive system to fertilize the eggs.
• Laparoscopy Diagnostic and treatment procedure effective for endometriosis, ovarian cystectomy, myomectomy, treating anatomical abnormalities, and lysis of uterine adhesions.
• Hysteroscopy Diagnostic and surgical procedure used to identify and treat causes of infertility such as fibroids, polyps, and other anatomical defects.
• Blastocyst Culture and Embryo Transfer Part of IVF/ICSI where the embryo is cultured for 5–6 days before being transferred into the woman's uterus for implantation and pregnancy.
• Laser Assisted Hatching (LAH) Clinical procedure that assists IVF treatment by creating an opening in the embryo's outer shell to increase chances of successful implantation.
• Cryopreservation Fertility preservation service covering oocyte (egg) freezing, sperm cryopreservation, and embryo cryopreservation for future frozen embryo transfer.
• Ovum Donor (Egg Donor) Program Third-party reproduction program using eggs from a donor when the female partner is unable to produce healthy eggs for fertilization.

Quantifiable outcome

• 72%+ overall IVF success rate based on positive pregnancy blood tests from IVF procedures at own and operated clinics in India during FY2025
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

One partnership is on record.

• Abha Surgy Healthcare Pvt LtdminorOthers · 16 April 2026Indira IVF acquired Kolkata-based Abha Surgy Healthcare Pvt Ltd as part of its expansion strategy in preparation for a planned Rs 3,500 crore IPO. This represents a strategic acquisition to strengthen presence in the Eastern India market.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Bloom Fertility Center: India-based fertility clinic chain offering IVF, IUI, ICSI, and male infertility treatments with multiple centers. Comparable as a directly competing specialty fertility chain with similar technology stack and pricing.
• Nova IVF Fertility: One of India's largest pure-play IVF chains with ~100 centers across the country. Directly comparable as a multi-center fertility chain offering IVF, ICSI, IUI, and advanced ART with similar patient demographic.
• ART Fertility Clinics: Multi-country IVF chain (UAE, India) offering comprehensive fertility services with strong technology emphasis. Comparable as an advanced-ART-focused chain competing for premium patients in Indian metros.
• Cloudnine Fertility: Indian fertility and maternity hospital chain backed by private equity, offering IVF, IUI, and ICSI with a strong metro presence. Comparable as a PE-backed, multi-city specialty fertility provider competing for the same patient cohort.
• Oasis Fertility: Single-specialty IVF chain operating across multiple Indian states with standardized protocols. Comparable as a regional-to-pan-India fertility chain targeting similar ART patients with comparable service menus.
• Medicover Fertility: European-headquartered fertility chain with significant India operations offering IVF, ICSI, and donor programs. Comparable as a multi-center fertility chain with standardized protocols and similar service breadth.

Broad incumbents

• Manipal Fertility: Fertility arm of Manipal Hospitals, a large hospital group. Comparable as a national fertility service provider operating within a broader hospital network rather than as a focused single-specialty chain.
• Apollo Fertility: Fertility arm of Apollo Hospitals, one of India's largest hospital chains. Comparable as a national fertility provider, but operates as part of a broader multi-specialty hospital portfolio rather than as a single-specialty focused chain.
• Fortis La Femme (Fertility): Women's health and fertility services under Fortis Healthcare, a major hospital chain. Comparable as a national fertility services provider operating within a multi-specialty hospital infrastructure.

Emerging players

• Motherhood Fertility & IVF: Indian fertility chain focused on advanced reproductive technology with growing metro presence. Comparable as an emerging multi-center IVF player pursuing similar patient outcomes through standardized lab technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/IVFIndira
• YouTubeyoutube.com/@Indiraivf
• Facebookfacebook.com/IndiraIVF
• LinkedInlinkedin.com/company/indira-ivf
• Instagraminstagram.com/indiraivfgroup

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Indira IVF